更多新聞公告 一月24, 2025 Signify's fourth quarter and full-year results 2024 十月25, 2024 Signify's third quarter results 2024 七月26, 2024 Signify's second quarter results 2024 所有新聞公告
Signify N.V.: News, information and stories for Signify N.V. | Euronext Amsterdam: LIGHT | Euronext Amsterdam
Signify said it would increase its cash dividend to 1.56 euros per share for 2024, from 1.55 euros paid for the prior year. It also unveiled a share repurchase programme of up to 150 million euros starting from the first quarter, and said it planned to buy back between...
SCHD Schwab Us Dividend Equity Etf $25.28 -1.45 -5.42% VOO Vanguard S&P 500 Etf $465.52 -28.64 -5.80% MINT Pimco Enhanced Short Maturity Active Exchange-Traded Fund $100.17 -0.10 -0.10% Trending Indexes Data as of Apr 6, 2025 COMP Nasdaq Composite Index 15,587.79 -962.82 -5.82% ...
52 Week Low Date03/04/25 Market Cap2,859.3M Shares Out126.17M 10 Day Average Volume392,537.7 Dividend1.56 Dividend Yield7.64% Beta1.02 YTD % Change-5.38 RATIOS/PROFITABILITY EPS (TTM)2.60 P/E (TTM)7.86 Fwd P/E (NTM)- EBITDA (TTM)- ...
Thanks to these achievements, we are updating our capital allocation policy. We will increase our dividend to 1.56 EUR per share in 2025 and will launch a share buyback program in Q1 of up to EUR 150 million to be executed by year-end. This is part of a planned EUR 350-450 million ...
Signify reports full-year sales of EUR 6.7 billion, operational profitability of 10.0% and a free cash flow of 8.7% of sales.
Get the latest Signify Health Inc. Class A (SGFY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
June 5, 2023 Dividend payment dateJuly 28, 2023 Second quarter and half-year results 2023 October 27, 2023 Third quarter results 2023 For further information, please contact:Signify Investor RelationsThelke GerdesTel: +31 6 1801 7131E-mail: the...
Dividend N/A Ex-Dividend Date N/A Short Interest N/A % of Float Shorted N/A Average Volume 465.42 Performance 5 Day 16.75% 1 Month 16.75% 3 Month 13.40% YTD 8.72% 1 Year -13.85% Analyst Ratings Sell Under Hold Over Buy Number of Ratings 13 Full Ratings Recent News Mark...